Thomas Jefferson University

Valerie Sampson

TitleVolunteer Faculty
InstitutionThomas Jefferson University
DepartmentFaculty Records
Address833 Chestnut Street
Philadelphia PA 19107
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Sampson VB, Vetter NS, Zhang W, Patil PU, Mason RW, George E, Gorlick R, Kolb EA. Retraction: Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma. Oncotarget. 2024 Oct 11; 15:725. PMID: 39392376.
      Citations:    
    2. D'Cruz RJ, Sampson VB, Askinas CA, Scott RA, Robinson KG, Beaty CA, Hesek As AM, Akins RE. Retraction notice to "Neointimal hyperplasia after carotid transection and anastomosis surgery?is?associated with degradation of decorin and platelet-derived growth factor signaling" [JVS-Vascular Science 2 (2021) 2 - 12]. JVS Vasc Sci. 2024; 5:100216. PMID: 39544907.
      Citations:    
    3. D'Cruz RJ, Sampson VB, Askinas CA, Scott RA, Robinson KG, Beaty CA, Hesek AM, Akins RE. Neointimal Hyperplasia after Carotid Transection and Anastomosis Surgery is Associated with Degradation of Decorin and Platelet Derived Growth Factor Signaling. JVS Vasc Sci. 2021; 2:2-12. PMID: 33842897.
      Citations:    
    4. D'Cruz RJ, Currier AW, Sampson VB. Laboratory Testing Methods for Novel Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2). Front Cell Dev Biol. 2020; 8:468. PMID: 32582718.
      Citations:    
    5. Currier AW, Kolb EA, Gorlick RG, Roth ME, Gopalakrishnan V, Sampson VB. p27/Kip1 functions as a tumor suppressor and oncoprotein in osteosarcoma. Sci Rep. 2019 04 16; 9(1):6161. PMID: 30992462.
      Citations:    
    6. Mills CC, Kolb EA, Sampson VB. Development of Chemotherapy with Cell-Cycle Inhibitors for Adult and Pediatric Cancer Therapy. Cancer Res. 2018 01 15; 78(2):320-325. PMID: 29311160.
      Citations:    
    7. Mills CC, Kolb EA, Sampson VB. Recent Advances of Cell-Cycle Inhibitor Therapies for Pediatric Cancer. Cancer Res. 2017 12 01; 77(23):6489-6498. PMID: 29097609.
      Citations:    
    8. Alleyne T, Ignacio DN, Sampson VB, Ashe D, Wilson M. Simulating the slow to fast switch in cytochrome c oxidase catalysis by introducing a loop flip near the enzyme's cytochrome c (substrate) binding site. Biotechnol Appl Biochem. 2017 Sep; 64(5):677-685. PMID: 27489224.
      Citations:    
    9. Vetter NS, Kolb EA, Mills CC, Sampson VB. The Microtubule Network and Cell Death Are Regulated by an miR-34a/Stathmin 1/?III-Tubulin Axis. Mol Cancer Res. 2017 07; 15(7):953-964. PMID: 28275089.
      Citations:    
    10. Sampson VB, Vetter NS, Zhang W, Patil PU, Mason RW, George E, Gorlick R, Kolb EA. Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma. Oncotarget. 2016 Dec 27; 7(52):86594-86607. PMID: 27863409.
      Citations:    
    11. Sampson VB, Vetter NS, Kamara DF, Collier AB, Gresh RC, Kolb EA. Vorinostat Enhances Cytotoxicity of SN-38 and Temozolomide in Ewing Sarcoma Cells and Activates STAT3/AKT/MAPK Pathways. PLoS One. 2015; 10(11):e0142704. PMID: 26571493.
      Citations:    
    12. Sampson VB, Yoo S, Kumar A, Vetter NS, Kolb EA. MicroRNAs and Potential Targets in Osteosarcoma: Review. Front Pediatr. 2015; 3:69. PMID: 26380245.
      Citations:    
    13. Kolb EA, Sampson V, Stabley D, Walter A, Sol-Church K, Cripe T, Hingorani P, Ahern CH, Weigel BJ, Zwiebel J, Blaney SM. A phase I trial and viral clearance study of reovirus (Reolysin) in children with relapsed or refractory extra-cranial solid tumors: a Children's Oncology Group Phase I Consortium report. Pediatr Blood Cancer. 2015 May; 62(5):751-8. PMID: 25728527.
      Citations:    
    14. Sampson VB, David JM, Puig I, Patil PU, de Herreros AG, Thomas GV, Rajasekaran AK. Wilms' tumor protein induces an epithelial-mesenchymal hybrid differentiation state in clear cell renal cell carcinoma. PLoS One. 2014; 9(7):e102041. PMID: 25025131.
      Citations:    
    15. Hingorani P, Sampson V, Lettieri C, Kolb EA. Oncolytic viruses for potential osteosarcoma therapy. Adv Exp Med Biol. 2014; 804:259-83. PMID: 24924179.
      Citations:    
    16. Sampson VB, Kamara DF, Kolb EA. Xenograft and genetically engineered mouse model systems of osteosarcoma and Ewing's sarcoma: tumor models for cancer drug discovery. Expert Opin Drug Discov. 2013 Oct; 8(10):1181-9. PMID: 23844615.
      Citations:    
    17. Sampson VB, Gorlick R, Kamara D, Anders Kolb E. A review of targeted therapies evaluated by the pediatric preclinical testing program for osteosarcoma. Front Oncol. 2013; 3:132. PMID: 23755370.
      Citations:    
    18. Ashe D, Alleyne T, Sampson V. Substrate binding-dissociation and intermolecular electron transfer in cytochrome c oxidase are driven by energy-dependent conformational changes in the enzyme and substrate. Biotechnol Appl Biochem. 2012 May-Jun; 59(3):213-22. PMID: 23586831.
      Citations:    
    19. Huynh TP, Mah V, Sampson VB, Chia D, Fishbein MC, Horvath S, Alavi M, Wu DC, Harper J, Sarafian T, Dubinett SM, Langhans SA, Goodglick L, Rajasekaran AK. Na,K-ATPase is a target of cigarette smoke and reduced expression predicts poor patient outcome of smokers with lung cancer. Am J Physiol Lung Cell Mol Physiol. 2012 Jun 01; 302(11):L1150-8. PMID: 22345575.
      Citations:    
    20. Tummala R, Wolle D, Barwe SP, Sampson VB, Rajasekaran AK, Pendyala L. Expression of Na,K-ATPase-beta(1) subunit increases uptake and sensitizes carcinoma cells to oxaliplatin. Cancer Chemother Pharmacol. 2009 Nov; 64(6):1187-94. PMID: 19322565.
      Citations:    
    21. Sampson VB, Dunn SP, Rymeski B, Malatack J, Rong NH, Flynn L, Krueger LJ. Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients. J Pediatr Surg. 2008 Jun; 43(6):1134-41. PMID: 18558196.
      Citations:    
    22. Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P, Petrelli NJ, Dunn SP, Krueger LJ. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res. 2007 Oct 15; 67(20):9762-70. PMID: 17942906.
      Citations:    
    Sampson's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (148)
    Explore
    _
    Co-Authors (7)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _